The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy

Annals of Surgery

Volumn 243, Issue 2, 2006, Pages 250-256

  Coffey, John Calvin ^a   Wang, Jiang H ^a   Bouchier Hayes, David ^b   Cotter, Tom G ^a   Redmond, H Paul ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DIMETHYL SULFOXIDE; EOSIN; HEMATOXYLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER GROWTH; CANCER RECURRENCE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LUNG METASTASIS; MITOSIS; MOUSE; NICK END LABELING; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN TARGETING; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CHROMONES; ENZYME INHIBITORS; IN SITU NICK-END LABELING; LAPAROTOMY; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MORPHOLINES; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 31844432409     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000197712.71055.12     Document Type: Article

References (49)

1. Tagliabue E, Agresti R, Carcangiu ML, et al. Role of HER2 in wound-induced breast carcinoma proliferation. Lancet. 2003;362:527-533.
2. Spigel. DR. HER2 and surgery: more questions to answer. Lancet 2003;362:502.
3. Qadri S, Wang JH, Coffey JC, et al. Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition. Ann Thorac Surg. 2004;79:990-995.
4. Pidgeon GP, Harmey JH, Kay E, et al. The role of endotoxin/ lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. Br J Cancer. 1999;81:1311-1317.
5. Coffey JC, Wang JH, Smith MJ, et al. Phosphoinositide 3 kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis: novel role for an old enemy. J Biol Chem. 2005;March 01(ePub ahead of print).
6. Coffey JC, Wang JH, Cotter TG, et al. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol. 2003;4:760-768.
7. Southall JC, Lee SW, Allendorf JD, et al. Colon adenocarcinoma and B-16 melanoma grow larger following laparotomy vs. pneumoperitoneum in a murine model. Dis Colon Rectum. 1998;41:564-569.
8. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-285.
9. Oliver RT. Does surgery disseminate or accelerate cancer? Lancet. 1995;346:1506-1507.
10. Lee SW, Gleason NR, Southall JC, et al. A serum-soluble factor(s) stimulates tumor growth following laparotomy in a murine model. Surg Endosc. 2000;14:490-494.
11. Lange PH, Hekmat K, Bosl G, et al. Accelerated growth of testicular cancer after cytoreductive surgery. Cancer. 1980;45:1498-1506.
12. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149-153.
13. Lacy AM, Garcia-Valdecasas JC, Delgado S, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet. 2002;359:2224-2229.
14. Gutt CN, Riemer V, Kim ZG, et al. Impact of laparoscopic colonic resection on tumour growth and spread in an experimental model. Br J Surg. 1999;86:1180-1184.
15. Da Costa ML, Redmond HP, Finnegan N, et al. Laparotomy and laparoscopy differentially accelerate experimental flank tumour growth. Br J Surg. 1998;85:1439-1442.
16. Bouvy ND, Marquet RL, Jeekel J, et al. Laparoscopic surgery is associated with less tumour growth stimulation than conventional surgery: an experimental study. Br J Surg. 1997;84:358-361.
17. Tyzzer E. Factors in the production and growth of tumour metastases. J Med Res. 1913;28:309-322.
18. Jones F, Rous P. On the localisation of secondary tumour at points of injury. Monogr Rockefeller Inst Med Res. 1914:404-412.
19. Ellis H. A History of Surgery, London: Greenwich Medical Media, 2001.
20. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315-328.
21. Cao Y, O'Reilly MS, Marshall B, et al. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J Clin Invest. 1998;101:1055-1063.
22. Nam SY, Jung GA, Hur GC, et al. Upregulation of FLIP(s) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in gastric cancers. Cancer Sci. 2003;94:1066-1073.
23. Kandasamy K, Srivastava RK. Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells. Cancer Res. 2002;62:4929-4937.
24. Hu Q, Klippel A, Muslin AJ, et al. Ras-dependent induction of cellular responses by constitutively active phosphoinositide 3-kinase. Science. 1995;268:100-102.
25. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231-241.
26. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296: 1655-1657.
27. Weaver SA, Ward SG. Phosphoinositide 3-kinases in the gut: a link between inflammation and cancer? Trends Mol Med. 2001;7:455-462.
28. Vivanco I, Sawyers CL. The phosphatidyl-inositol 3-kinase-Akt pathway in human cancer. Nat Rev Cancer. 2002;2:489-501.
29. Shayesteh L, Lu Y, Kuo WL, et al. PI3KCA is implicated as an oncogene in ovarian cancer. Nat Genet. 1999;21:99-102.
30. Da Costa ML, Redmond P, Bouchier-Hayes DJ. The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery. 1998;124:516-525.
31. Coffey JC, Doyle M, O'Mahony L, et al. Probiotics confer protection against perioperative metastatic tumour growth. Ann Surg Oncol. 2002; 9:93.
32. Coffey JC, Bennett MW, Wang JH, et al. Upregulation of Fas-Fas-L (CD95/CD95L)-mediated epithelial apoptosis: a putative role in pouchitis? J Surg Res. 2001;98:27-32.
33. Pidgeon GP, Barr MP, Harmey JH, et al. Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer. 2001;85:273-278.
34. Lee JY, Murphy SM, Scanlon EF. Effect of trauma on implantation of metastatic tumor in bone in mice. J Surg Oncol. 1994;56:178-184.
35. Yuan XJ, Whang YE. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene. 2002;21:319-327.
36. Ueki K, Fruman DA, Brachmann SM, et al. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol. 2002;22:965-977.
37. Wei LH, Kuo ML, Chen CA, et al. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by upregulation of Mc-1 through a PI3K/Akt pathway. Oncogene. 2001;20:5799-5809.
38. Hu L, Zaloudek C, Mills GB, et al. In vivo and in vitro ovarian cancer growth inhibition by phosphoinositide 3 kinase inhibitor (LY294002). Clin Cancer Res. 2000;6:880-886.
39. Hu L, Hofmann J, Mills GB, et al. Inhibition of phosphatidyl-inositol 3-kinase increases efficacy of paclitaxel in in-vitro and in-vivo ovarian cancer cell models. Cancer Res. 2002;62:1087-1092.
40. Demicheli R, Valagussa P, Bonadonna G. Does surgery modify growth kinetics of breast cancer micrometastases? Br J Cancer. 2001;85:490-492.
41. Demicheli R, Miceli R, Valagussa P, et al. Re: Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst. 2000;92:347-348.
42. Abramovitch R, Marikovsky M, Meir G, et al. Stimulation of tumour growth by wound-derived growth factors. Br J Cancer. 1999;79:1392-1398.
43. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420: 860-867.
44. Krasilnikov M, Ivanov VN, Dong J, et al. ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications for sensitisation to apoptosis. Oncogene. 2003;22:4092-4101.
45. Hofer SO, Shrayer D, Reichner JS, et al. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg. 1998;133:383-389.
46. Gutt CN, Riemer V, Kim ZG, et al. Impact of laparoscopic surgery on experimental hepatic metastases. Br J Surg. 2001;88:371-375.
47. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315: 1650-1659.
48. Da Costa ML, Redmond HP, Bouchier-Hayes DJ. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. J Surg Res. 2001;101:111-119.
49. Mauvais-Jarvis F, Ueki K, Cantley LC, et al. Reduced expression of murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest. 2002;109:141-149.